Findlay Park Partners LLP Buys 159,800 Shares of Danaher Corporation $DHR

Key Points

• Findlay Park Partners LLP has increased its stake in Danaher Corporation by 37.6%, owning 584,800 shares valued at approximately $119.88 million.
• Wall Street analysts have upgraded their ratings for Danaher, with 17 analysts giving it a "Buy" rating and the stock currently having a consensus price target of $247.61.
• Danaher recently reported strong quarterly earnings, exceeding expectations with an EPS of $1.80 and revenue of $5.94 billion, showing a 3.4% increase year-over-year.

Findlay Park Partners LLP boosted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 584,800 shares of the conglomerate's stock after purchasing an additional 159,800 shares during the quarter. Findlay Park Partners LLP owned about 0.08% of Danaher worth $119,884,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of DHR. Nuveen LLC acquired a new stake in Danaher in the 1st quarter valued at $833,941,000. GAMMA Investing LLC grew its position in Danaher by 24,958.2% in the 1st quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock valued at $383,524,000 after purchasing an additional 1,863,381 shares during the period. Two Sigma Advisers LP grew its position in Danaher by 4,248.8% in the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after purchasing an additional 1,601,800 shares during the period. Invesco Ltd. grew its position in Danaher by 44.5% in the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock valued at $965,259,000 after purchasing an additional 1,450,703 shares during the period. Finally, Point72 Asset Management L.P. grew its position in Danaher by 460.6% in the 4th quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock valued at $309,558,000 after purchasing an additional 1,107,998 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

Several analysts recently issued reports on DHR shares. UBS Group reduced their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. Barclays restated an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Wells Fargo & Company dropped their price objective on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft dropped their price objective on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Finally, Guggenheim restated a "buy" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $247.61.

Danaher Stock Performance

Danaher stock traded up $0.80 during midday trading on Friday, reaching $206.09. The stock had a trading volume of 1,979,809 shares, compared to its average volume of 3,319,294. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The firm's 50-day moving average price is $201.65 and its 200 day moving average price is $199.49. The firm has a market capitalization of $147.57 billion, a PE ratio of 43.85, a P/E/G ratio of 2.87 and a beta of 0.73. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. During the same period in the previous year, the business posted $1.72 EPS. The firm's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.